Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating ovarian cancer.

Literature DB >> 3094756

Treating ovarian cancer.

R W Burslem, P M Wilkinson.

Abstract

Entities: Disease

Mesh：

Year: 1986 PMID： 3094756 PMCID： PMC1341766 DOI： 10.1136/bmj.293.6553.972

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

12 in total

1. Intensive surgical and chemotherapeutic management of advanced ovarian cancer.

Authors: C T Griffiths; A F Fuller
Journal: Surg Clin North Am Date: 1978-02 Impact factor: 2.741

2. Advanced ovarian carcinoma: a prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF).

Authors: J Carmo-Pereira; F O Costa; E Henriques; J A Ricardo
Journal: Cancer Date: 1981-11-01 Impact factor: 6.860

3. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.

Authors: C E Ehrlich; L Einhorn; F B Stehman; J Blessing
Journal: Clin Obstet Gynaecol Date: 1983-08

4. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

Authors: R C Young; B A Chabner; S P Hubbard; R I Fisher; R A Bender; T Anderson; R M Simon; G P Canellos; V T DeVita
Journal: N Engl J Med Date: 1978-12-07 Impact factor: 91.245

5. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

Authors: J P Neijt; W W ten Bokkel Huinink; M E van der Burg; A T van Oosterom; R Vriesendorp; C D Kooyman; A C van Lindert; J V Hamerlynck; M van Lent; J C van Houwelingen
Journal: Lancet Date: 1984-09-15 Impact factor: 79.321

6. Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

Authors: C J Williams; G M Mead; F R Macbeth; J Thompson; J M Whitehouse; H MacDonald; V J Harvey; M L Slevin; T A Lister; J H Shepherd
Journal: J Clin Oncol Date: 1985-11 Impact factor: 44.544

7. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

Authors: S B Howell; C E Pfeifle; W E Wung; R A Olshen
Journal: Cancer Res Date: 1983-03 Impact factor: 12.701

8. Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin.

Authors: H W Bruckner; C J Cohen; J D Goldberg; B Kabakow; R C Wallach; G Deppe; E M Greenspan; S B Gusberg; J F Holland
Journal: Cancer Date: 1981-05-01 Impact factor: 6.860

9. Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum.

Authors: D R Bell; R L Woods; J A Levi; R M Fox; M H Tattersall
Journal: Aust N Z J Med Date: 1982-06

10. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

Authors: P A Canney; M Moore; P M Wilkinson; R D James
Journal: Br J Cancer Date: 1984-12 Impact factor: 7.640

1 in total

1. Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

Authors: S Marsoni; V Torri; M G Valsecchi; C Belloni; U Bianchi; G Bolis; C Bonazzi; N Colombo; A Epis; G Favalli
Journal: Br J Cancer Date: 1990-09 Impact factor: 7.640

1 in total